RIPK2 and diabetic kidney disease: RT-qPCR, western blot and IHC indicated that the expression of NOD2 and its downstream proteins including p-P65, p-RIP2 was significantly increased in DKD groups and decreased in MSCs-Exo and insulin treatment groups (Figure 7(b–e)).